Kiniksa Pharmaceuticals International Income Statement (2017-2026) | KNSA

Income Statement Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
7.70M12.10M18.75M32.19M26.97M99.14M-148.30M48.34M71.47M67.05M83.39M79.86M108.63M112.21M122.54M137.78M156.80M180.85M202.13M214.27M
Cost of Revenue (Quarter)
2.47M2.77M-4.40M4.22M5.03M6.94M6.71M0.49M7.70M9.09M9.58M10.58M12.32M20.11M17.90M17.87M18.60M20.26M20.95M20.80M
Gross Profit (Quarter)
5.24M9.33M23.14M27.97M21.94M92.20M-155.01M47.85M63.77M57.96M73.81M69.28M96.31M92.11M104.64M119.92M138.19M160.60M181.18M193.47M
Operating items
Research & Development (Quarter)
23.95M19.24M27.43M20.82M13.80M16.48M14.39M15.17M23.77M17.11M20.05M26.33M24.02M26.06M35.22M17.00M18.75M24.17M34.61M27.48M
Selling, General & Administrative (Quarter)
21.85M20.76M22.74M22.22M23.84M24.68M27.21M29.05M29.18M34.47M36.74M38.68M42.40M46.40M40.53M43.53M46.86M49.10M56.77M61.15M
Other Operating Expenses (Quarter)
2.47M2.77M4.70M12.47M8.70M11.56M14.23M15.32M21.68M26.40M26.52M31.38M42.34M49.42M66.08M63.98M71.02M83.56M90.97M96.37M
Operating Expenses (Quarter)
48.26M42.76M54.88M55.51M46.34M52.72M55.84M59.54M74.63M77.97M83.31M96.40M108.75M121.87M141.84M124.51M136.64M156.83M182.36M185.00M
Operating Income (Quarter)
-40.55M-30.67M-36.13M-23.32M-19.37M46.41M6.05M-11.20M-3.15M-10.93M0.08M-16.54M-0.12M-9.66M-19.30M13.27M20.16M24.02M-35.14M29.27M
EBIT (Quarter)
-40.55M-30.67M-36.13M-23.32M-19.37M46.41M6.05M-11.20M-3.15M-10.93M0.08M-16.54M-0.12M-9.66M-19.30M13.27M20.16M24.02M-35.14M29.27M
Non-operating items
Interest & Investment Income (Quarter)
0.01M0.01M0.08M0.03M0.10M0.32M
Other Non Operating Income (Quarter)
0.03M0.10M0.32M0.79M1.83M1.92M2.43M2.37M2.27M2.42M2.46M2.32M2.29M2.72M3.14M3.50M3.41M
Net income details
EBT (Quarter)
-40.55M-30.66M-43.80M-23.29M-19.27M46.73M-88.25M-9.36M-1.24M-8.50M-72.03M-14.28M2.30M-7.20M-9.30M15.56M22.88M27.16M23.27M32.68M
Tax Provisions (Quarter)
1.01M-0.12M0.28M1.93M0.72M-177.36M2.38M2.91M-16.21M5.36M11.00M3.43M6.21M5.49M-8.09M7.03M5.04M8.72M9.07M10.09M
Profit After Tax (Quarter)
-41.56M-30.54M-36.33M-25.21M-19.98M224.09M4.46M-12.27M14.97M-13.86M25.24M-17.70M-3.91M-12.69M-8.89M8.54M17.83M18.43M14.20M22.59M
Income from Continuing Operations (Quarter)
-41.56M-30.54M-44.08M-25.21M-19.98M224.09M-90.63M-12.27M14.97M-13.86M-83.03M-17.70M-3.91M-12.69M-1.21M8.54M17.83M18.43M14.20M22.59M
Consolidated Net Income (Quarter)
-41.56M-30.54M-44.08M-25.21M-19.98M224.09M-90.63M-12.27M14.97M-13.86M-83.03M-17.70M-3.91M-12.69M-1.21M8.54M17.83M18.43M14.20M22.59M
Income towards Parent Company (Quarter)
-41.56M-30.54M-44.08M-25.21M-19.98M224.09M-90.63M-12.27M14.97M-13.86M-83.03M-17.70M-3.91M-12.69M-1.21M8.54M17.83M18.43M14.20M22.59M
Net Income towards Common Stockholders (Quarter)
-41.56M-30.54M-44.08M-25.21M-19.98M224.09M-90.63M-12.27M14.97M-13.86M-83.03M-17.70M-3.91M-12.69M-1.21M8.54M17.83M18.43M14.20M22.59M
Additional items
EPS (Basic) (Quarter)
-0.61-0.44-0.52-0.36-0.293.230.06-0.180.21-0.200.36-0.25-0.06-0.18-0.120.120.240.250.190.30
EPS (Weighted Average and Diluted) (Quarter)
-0.61-0.44-0.52-0.36-0.293.180.05-0.180.21-0.200.36-0.25-0.06-0.18-0.120.110.230.230.180.27
Shares Outstanding (Weighted Average) (Quarter)
68.33M68.66M68.58M69.14M69.21M69.31M69.38M69.75M69.84M69.95M70.06M70.63M71.00M71.73M71.42M72.65M73.44M74.71M74.20M76.52M
Shares Outstanding (Diluted Average) (Quarter)
68.40M68.44M68.58M69.14M69.21M70.55M70.42M69.75M71.42M70.19M71.92M70.63M70.82M71.12M71.42M76.15M76.98M78.03M78.98M82.41M
EBITDA (Quarter)
-41.52M-30.62M-36.35M-25.25M-19.97M224.11M4.58M-12.26M14.93M-13.87M25.24M-17.76M-3.98M-12.60M-9.01M8.54M17.94M18.33M14.33M21.95M
Tax Rate (Quarter)
-2.50%0.38%-0.64%-8.27%-3.72%-379.50%-2.70%-31.03%1,308.39%-63.02%-15.27%-24.01%269.62%-76.27%86.95%45.14%22.05%32.12%38.98%30.87%